FAS and non-small cell lung carcinoma: In NSCLC A549 cells, FAS siRNA transfection could reduce the proliferation rate, migration and invasion ability through reducing ATP and lactic acid productions, suggesting a connection between fatty acid and glucose metabolism (Chang et al., 2019).